Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma

Clinical trial condition

Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma

Explore clinical trials studying Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma trial results

Active, Not Recruiting

Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma

NCT05821088

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +30 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

NCT05025800

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, +31 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details